Regulus and Glaxo Will Work on Hepatitis C Drugs
Lilly Settlement to Fund MT Mental Health Services
KV to Close Ethex Unit and Plead Guilty to Charges
Philippines to Lower Prices on More Medicines
Read the rest of this entry »
THE LATEST WORD
Top Industry News – February 26, 2010
Posted on February 26th, 2010 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – February 25, 2010
Posted on February 25th, 2010 | by Rxmedyn | No Comments »GSK Says Report on Avandia Ignores “Scientifically Sound” Info
Pfizer’s Prevnar 13 Recommended by CDC’s Advisory Committee On Immunization Practices
Posted in Industry Stories
Top Industry Stories – February 24, 2010
Posted on February 24th, 2010 | by Rxmedyn | No Comments »Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc.
Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
Posted in Industry Stories
Top Industry News – February 23, 2010
Posted on February 23rd, 2010 | by Rxmedyn | No Comments »Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic
Gardasil Approved By Health Canada for Males to Prevent Genital Warts
New Obama Health Plan Seeks $10B More from Pharma
Continues Review of Avandia, Saying Nothing Until July
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – February 22, 2010
Posted on February 22nd, 2010 | by Rxmedyn | No Comments »FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson’s Disease
Research Ties Diabetes Drug to Heart Woes – Feb. 20
GSK Defends Diabetes Drug as Avandia is Attacked Again in US
MediGene and Teva Sign Agreement To Commercialize Veregen in Israel
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – February 19, 2010
Posted on February 19th, 2010 | by Rxmedyn | No Comments »Vaccine For Diabetes Around The Corner – Report
Physicians Say No to DTC Advertising for Medications that Treat Mental Disorders
Pharmatek Gains DEA Approval for Controlled Substances
J&J Partner Says EU Rejecting Skin Infection Drug
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – February 18, 2010
Posted on February 18th, 2010 | by Rxmedyn | No Comments »Treatment Options Available for Women’s Pelvic Health Concerns
FDA Turns Down GSK/XenoPort’s RLS Drug
WHO: Add Swine Flu to Regular Flu Vaccine
Roche Releases Preliminary Data Of ATHENA Trial
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories
Posted on February 17th, 2010 | by Rxmedyn | No Comments »FDA backs REMS Plan For Amgen and J&J’s Anemia
Cholesterol Drugs Up Diabetes Risk Slightly: Study
Merc & Co Posts Strong Results, Unveils 17,500 Job Cut Plans
Lilly’s Effient Is a Slow Starter
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories
Posted on February 16th, 2010 | by Rxmedyn | No Comments »Teva Pharmaceutical Reports 4th-Quarter Profit
One In Five Europeans Buying Fake Drugs – Pfizer Survey
US health “Spent More Than Any Group Ever” On Lobbying In 2009
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – February 12, 2010
Posted on February 12th, 2010 | by Rxmedyn | No Comments »Billy Tauzin Stepping Down as Head of PHARMA
Big Pharmaceutical Companies Lead The Way In Copd Drug Development
Court denies Pfizer petition to block generic drug variant
Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics